$WORX

SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement - SCWorx (NASDAQ:WORX)

Middleton, MA, Oct. 14, 2025 ( GLOBE NEWSWIRE ) -- SCWorx Corp ( NASDAQ:WORX ) ( "SCWorx" or the "Company" ) , a software-as-a-service company focused on data management for healthcare providers received written notification from the Listing Qualification Department of The Nasdaq Stock Market ...

Original reporting
Benzinga · Globe Newswire
Published Oct 14, 2025, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2025, 3:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SCWorx Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement - SCWorx (NASDAQ:WORX) — source image
Decision brief

The 30-second read

$WORXNeutralLow
01

Why it matters

The 180-day extension provides temporary relief, potentially stabilizing the stock price and reducing immediate delisting risk.

02

Market read

The news is relevant to investors holding or considering trading SCWorx shares, with limited broader market impact.

03

What to watch

Potential for future regulatory hurdles or financial difficulties that could still adversely affect the stock.

Timing: short-term (within days to weeks)

Background

SCWorx is facing regulatory scrutiny and needs to meet NASDAQ's minimum bid price requirement to avoid delisting.

Company-level read

Ticker impact

$WORXNeutralMedium confidence
Context

The news pertains directly to SCWorx, a NASDAQ-listed healthcare data management company, and may influence its stock performance.

Expected impact

Minimal short-term price movement; potential stabilization around current levels.

Evidence & confidence

The news is procedural and does not indicate fundamental changes; market reaction may be limited.

Market effects

Healthcare data management sector may see stability as companies face regulatory compliance challenges.

Limited regional impact; specific to NASDAQ-listed companies.

Low; primarily affects US-based healthcare technology firms.

Counterpoint

The extension may be viewed skeptically if investors interpret it as a sign of ongoing compliance issues or underlying company struggles.

Key entities

  • SCWorx Corp

    A healthcare data management software company listed on NASDAQ.

  • NASDAQ Stock Market

    The US-based stock exchange requiring SCWorx to meet minimum bid price standards.

Related articles

Med

SCWorx Corp.: SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company's Continued Listing on the Nasdaq Capital Market

SCWorx Corp. said Nasdaq’s Hearings Panel issued a partial compliance letter confirming completion of the first benchmark in its approved plan to regain compliance for continued listing. The remaining requirement is to meet the Nasdaq minimum bid price of at least $1.00 for 20 consecutive trading days, under Listing Rule 5815(c)(4).

$CWMed

Curtiss-Wright Slides As Investors Question CEO Handoff

Curtiss-Wright (CW) shares fell as investors reacted to a planned leadership transition, with the current COO set to become CEO in 2027. Concerns about strategic continuity and execution risk were raised, despite the company's strong financial position and growth prospects. Quarterly results may be volatile due to cash conversion and supply chain pressures.

$HCAMed

BMO starts HCA Healthcare stock at Outperform on growth outlook

BMO Capital initiated coverage on HCA Healthcare (NYSE:HCA) with an Outperform rating and $495 price target, citing growth drivers like demographic trends and digital transformation. HCA trades at $438.16 with $95.43B market cap, and reported Q2 2026 earnings beating estimates but lowered full-year guidance. Analysts have mixed reactions with varied price targets and ratings.

$BAMed

Boeing wins $33.4 million Air Force avionics contract

Boeing (BA) secured a $33.4M contract from the U.S. Department of War for C-17 Avionics Integration work, with completion expected by April 2032. The contract, awarded via a sole-source process, addresses obsolescence and maintains lab functionality. Funds were allocated from fiscal 2026 operations and maintenance budgets.